Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP645968.RAdEqgcJRcmgSpTG9aD3HaH7hVS4kyacZ2ZQYT3P2AnwQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP645968.RAdEqgcJRcmgSpTG9aD3HaH7hVS4kyacZ2ZQYT3P2AnwQ130_assertion type Assertion NP645968.RAdEqgcJRcmgSpTG9aD3HaH7hVS4kyacZ2ZQYT3P2AnwQ130_head.
- NP645968.RAdEqgcJRcmgSpTG9aD3HaH7hVS4kyacZ2ZQYT3P2AnwQ130_assertion description "[Small-molecule inhibitors of MEK1/MEK2 are therefore viewed as attractive drug candidates for the targeted therapy of this malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645968.RAdEqgcJRcmgSpTG9aD3HaH7hVS4kyacZ2ZQYT3P2AnwQ130_provenance.
- NP645968.RAdEqgcJRcmgSpTG9aD3HaH7hVS4kyacZ2ZQYT3P2AnwQ130_assertion evidence source_evidence_literature NP645968.RAdEqgcJRcmgSpTG9aD3HaH7hVS4kyacZ2ZQYT3P2AnwQ130_provenance.
- NP645968.RAdEqgcJRcmgSpTG9aD3HaH7hVS4kyacZ2ZQYT3P2AnwQ130_assertion SIO_000772 19014680 NP645968.RAdEqgcJRcmgSpTG9aD3HaH7hVS4kyacZ2ZQYT3P2AnwQ130_provenance.
- NP645968.RAdEqgcJRcmgSpTG9aD3HaH7hVS4kyacZ2ZQYT3P2AnwQ130_assertion wasDerivedFrom befree-20150227 NP645968.RAdEqgcJRcmgSpTG9aD3HaH7hVS4kyacZ2ZQYT3P2AnwQ130_provenance.
- NP645968.RAdEqgcJRcmgSpTG9aD3HaH7hVS4kyacZ2ZQYT3P2AnwQ130_assertion wasGeneratedBy ECO_0000203 NP645968.RAdEqgcJRcmgSpTG9aD3HaH7hVS4kyacZ2ZQYT3P2AnwQ130_provenance.